Vident Advisory’s British American Tobacco BTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.24M Buy
149,657
+61,969
+71% +$3.74M 0.07% 245
2026
Q1
$5.13M Buy
87,688
+41,027
+88% +$2.43M 0.04% 351
2025
Q4
$2.64M Sell
46,661
-4,549
-9% -$248K 0.02% 492
2025
Q3
$2.72M Buy
51,210
+10,978
+27% +$596K 0.03% 466
2025
Q2
$1.9M Buy
40,232
+3,427
+9% +$152K 0.02% 521
2025
Q1
$1.52M Buy
36,805
+3,511
+11% +$138K 0.02% 571
2024
Q4
$1.21M Sell
33,294
-231
-0.7% -$8.34K 0.02% 572
2024
Q3
$1.23M Sell
33,525
-2,451
-7% -$87.6K 0.03% 553
2024
Q2
$1.11M Buy
35,976
+2,584
+8% +$78.5K 0.03% 558
2024
Q1
$1.02M Sell
33,392
-1,788
-5% -$53.8K 0.02% 564
2023
Q4
$1.03M Buy
35,180
+1,422
+4% +$43.3K 0.03% 551
2023
Q3
$1.06M Buy
+33,758
New +$1.11M 0.03% 489

Other funds holding BTI

Vident Advisory's BTI Position: Q2 2026 in Review

Vident Advisory increased its British American Tobacco (BTI) stake by 71% in Q2 2026, buying an estimated $3.74M and bringing the position to 149,657 shares worth $9.24M. The position accounts for 0.07% of the portfolio, ranked #245.

Vident Advisory first reported a position in BTI in Q3 2023 and has held it in 12 quarters since. 910 funds tracked by Wall St. Rank hold BTI as of Q2 2026.

  • Vident Advisory held 149,657 shares of British American Tobacco worth $9.24M as of Q2 2026.
  • Vident Advisory bought 61,969 British American Tobacco shares in Q2 2026, an estimated $3.74M.
  • British American Tobacco made up 0.07% of Vident Advisory's portfolio in Q2 2026, its #245 holding.
  • Vident Advisory first reported a position in British American Tobacco in Q3 2023 and has held it in 12 quarters since.
  • 910 funds tracked by Wall St. Rank held British American Tobacco as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.